Board Members

Our Challenges Don’t Define Us.
Our Actions Do.

The Choroideremia Research Foundation (CRF) is the largest organization in the world focused on the search for a cure for choroideremia (CHM). Our mission is to raise funds in support of scientific research leading to a treatment or cure of choroideremia, a hereditary retinal-degenerative disease that causes blindness; to educate people affected by the disease; and to inform the public.

Founded in 2000, a small group of individuals affected with CHM formed the CRF to make a difference for themselves, their families and the many others living with this disease. There are an estimated 6,600 affected male CHMers in the United States.

Our Achievements and History

CRF has funded over $5 million in research on the causes and potential cures for choroideremia since being granted nonprofit status in 2000.

The organization hosts regular conferences for patients and families as well as scientific symposia for researchers and clinicians. It also offers one-day regional meetings several times a year around the world. Webinars and interactive online chats are offered (and recorded) several times monthly on topics such as emotional support, research, assistive technology, clinical trials and genetic testing.

In August 2021, the CRF spearheaded the launch of the International Choroideremia Research Network (ICRN), a global alliance of researchers from around the world who are working in concert to accelerate scientific knowledge about CHM. The network is composed of nearly 140 multi-disciplinary vision professionals with varied experiences, backgrounds, and interests from 25 countries.

CRF was conceived by a small group of patients in 1999. It formally established nonprofit status in 2000 and began funding research in 2002. A few of CRF’s first early research projects included establishment of a CHM mouse model, creating induced pluripotent stem cell (iPSC) models, formation of a human CHM cell biobank, and support of several pre-clinical gene therapy research studies which ultimately led to launch of three clinical trials.

CRF is now exploring collaborations and/or funding development of a CHM pig model, possible pharmaceutical therapies, gene therapy, optogenetics (light sensing), neuroprotection (to delay progression), RNA and DNA editing, stem cell therapy, sight replacement therapies, transplantation, assistive/bionic technologies, and understanding genetics and phenotypes (characteristics and variations) of CHM cells and how these differences may affect progression and outcomes.

State of CRF Video

To learn more about CRF’s recent accomplishments, please view our State of the CRF webinar.

Our Board of Directors


Neal Bench, MBA, CPA | President
Chapel Hill, NC – Retired from manufacturing finance. Actively volunteers on several nonprofit committees & boards

John Trott, MBA | 1st Vice-President
Westfield, NJ – Retired pharmaceutical executive

Michael Mullen | 2nd Vice-President
Carmel, Indiana – Senior VP of Investments, Portfolio Management Director at Morgan Stanley

Kayla Schiller | Treasurer
Claflin, Kansas – Senior Tax Manager at GE

Brian Mayer | Secretary
Brookfield, Illinois – Customer Care Manager at Ace Hardware Corp


Tara Cassidy-Driscoll | At-Large
Swampscott, Massachusetts – Owner and CEO of Cassidy Insurance

Stephanie Sims, MD | At-Large
Jacksonville, Florida – Child and Adolescent Psychiatrist, Baptist Medical Center


Brian Counter
Champaign, Illinois – Retired Senior Research Analyst, Parkland College

Thomas Driscoll
Swampscott, Massachusetts – Business Development Representative, Kantata

Naama Goldman-Einhorn, PhD
Tel-Aviv, Israel – Clinical psychologist

Aurelie Harp
New York, New York – Founder, Womanity Project and Womanity Play

Bob Hillier
Ontario, Canada – Retired hydrogeologist, a founding board member of the CRF

Michael Laengsfeld
Friedberg/Hessen, Germany – CEO at DVBS, VP at Commerzbank AG

Jason McKinney, MBA
Gilmer, Texas – Former restauranteur & City Councilman in Colfax, CA, a founding board member of the CRF

Rachel Oster
Rochester, New York – Real Estate Agent

Mary Porter, JD
Manchester, New Hampshire –  Attorney, Finch and Maloney

Yamil Rosete Rodriguez
New York, New York – Senior Software Engineer, MasterCard

John-Ross Rizzo, MD
New York, New York – Associate Professor, NYU Langone Medical Center, Dept. of Rehabilitation Medicine and Dept of Neurology

Craig Rowley
Jay, Maine – Workforce Management Analyst at WEX, Inc

Jon Salois
Worcester, Massachusetts – VP of Sales for Atlas Distributing

Choroideremia Research Foundation Staff

Kathi Wagner | Executive Director; Tampa, Florida

Reagan Devinney | Digital Marketing Coordinator; Olathe, Kansas
Beth Foss | Director of Operations; Lancaster County, Pennsylvania
Eric Hartman | Director of Advocacy; New Orleans, Louisiana
Cory MacDonald | Engagement Director; Springfield, Massachusetts

Our Science Advisory Board

Tomas Aleman, MD | Professional webpage
Director of the Retinal Structure and Function Laboratory, Perelman Center for Advanced Medicine, Perelman School of Medicine, University of Pennsylvania
Philadelphia, Pennsylvania

Brian Ballios, MD, PhD, FRCSC, DABO | Professional webpage
Assistant Professor in the Department of Ophthalmology and Vision Sciences at the University of Toronto
Toronto, Canada

Malia Edwards, PhD | Professional webpage
Assistant Professor of Ophthalmology, Johns Hopkins Medicine, Baltimore
Baltimore, Maryland

Rachel Huckfeldt, MD, PhD | Professional webpage
Academic Vice Chair,  Science Advisory Board, Choroideremia Research Foundation; Physician and Surgeon and Director, Inherited Retinal Degenerations Fellowship, Massachusetts Eye and Ear; Assistant Professor of Ophthalmology, Harvard Medical School
Boston, Massachusetts

Alex Iannaccone, MD, MS, FARVO | Professional webpage
Global Medical Lead, Cell and Gene Therapy – Ophthalmology, Duke University Department of Ophthalmology
Durham, North Carolina

Jasleen Kaur Jolly, DPhil, MSc, BSc (Hons), MCOptom | Professional webpage
Senior Clinical Research Fellow, Oxford Neuroscience, Cambridge, UK
Cambridge, UK

Maureen McCall, PhD | Professional webpage
Academic Chair,  Science Advisory Board, Choroideremia Research Foundation; Professor & Vice Chair for Research, Department of Ophthalmology & Visual Sciences, School of Medicine, University of Louisville
Louisville, Kentucky

Chris Moen, MD | Professional webpage
Chief Medical Officer, Choroideremia Research Foundation; Medical Director, NaviHealth
Wilmington, Delaware

Ruchi Sharma, PhD | Professional webpage
Senior Staff Scientist, Ophthalmic Genetics and Visual Function Branch, National Eye Institute
Bethesda, Maryland

Divya Sinha, PhD | Professional webpage
Scientist I, David Gamm Laboratory, Waisman Center, University of Wisconsin- Madison
Madison, Wisconsin

Jess Thompson, MD, MS | Professional webpage
Chair, Science Advisory Board, Choroideremia Research Foundation; Cardiothoracic Surgeon, Yavapai Cardiac Surgery
Prescott, Arizona

Stephen Tsang, MD, PhD | Professional webpage
Professor of Ophthalmology and Professor of Pathology and Cell Biology, Columbia University Department of Pathology and Cell Biology
New York, New York

Ajoy Vincent, MBBS, MS | Professional webpage
Staff Ophthalmologist, Ophthalmology and Vision Sciences; Medical Director, Visual Electrophysiology Unit; Associate Scientist Genetics and Genome Biology Research Institute, The Hospital for Sick Children
Toronto, Ontario, Canada

Michael Young, PhD, FARVO | Professional webpage
Associate Professor of Ophthalmology, Co-Director, Ocular Regenerative Medicine Institute; Director, Minda de Gunzburg Center for Retinal Regeneration, Harvard Medical School; Associate Scientist, Schepens Eye Research Institute of Massachusetts Eye and Ear
Boston, Massachusetts

Our Emeritus Science Advisory Board Members

Ian MacDonald MSc, MD, CM | Professional webpage
Professor Emeritus in the Department of Ophthalmology and Visual Sciences, University of Alberta and past Chair of the Department
Alberta, Canada

Our Publications

If you would like to receive print copies of any of our publications, please contact Cory MacDonald.

Our Financial Information

Contributions given to CRF are carefully managed to provide the greatest benefit to those research efforts receiving its funds.

CRF is audited on an annual basis. An Investment Committee comprised of experienced financial industry volunteers oversees the management of funds.

CRF Audits

Strategic Plan